Mesoblast (MESO) Return on Capital Employed (2017 - 2023)

Mesoblast's (MESO) quarterly Return on Capital Employed came in at 110.04% in Q2 2023, up 10803.0% year-on-year from N/an in Q2 2022, and down 1.75% quarter-over-quarter from 112.0% in Q1 2023.

Mesoblast (MESO) Return on Capital Employed (2017 - 2023) Analysis & Trends

Mesoblast has disclosed Return on Capital Employed across 7 years of filings, most recently posting 110.04% for Q2 2023.

  • Return on Capital Employed for Q2 2023 came in at 110.04%, up 10803.0% year-over-year; the trailing twelve-month figure through Jun 2023 was 110.04% (up 10803.0% YoY), and the FY2025 annual result was 9.94%, up 92.0% from the prior year.
  • Return on Capital Employed came in at 110.04% for Q2 2023 at Mesoblast, down from 112.0% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 822.31% in Q2 2021 to a low of 368.88% in Q1 2020.
  • The 5-year median for Return on Capital Employed is 106.1% (2021), against an average of 102.43%.
  • Across the five-year window, Return on Capital Employed jumped 83040 bps in 2021 and tumbled 82031 bps in 2022, its largest moves.
  • Mesoblast's Return on Capital Employed stood at 306.35% in 2019, then surged by 158 bps to 176.64% in 2020, then jumped by 195 bps to 521.85% in 2021, then sank by 72 bps to 143.58% in 2022, then slipped by 23 bps to 110.04% in 2023.
  • The last three Return on Capital Employed figures came in at 110.04% (Q2 2023), 112.0% (Q1 2023), and 143.58% (Q4 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 450.31%
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 51.73%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -107.40%
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 21.10%
9 Abivax 91.96 Bn 91.96 Bn - -50.43%
10 Mesoblast 21.68 Bn 21.55 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2023 110.04%
Mar 31, 2023 112.00%
Dec 31, 2022 143.58%
Sep 30, 2022 119.17%
Jun 30, 2022 2.00%
Mar 31, 2022 627.50%
Dec 31, 2021 521.85%
Sep 30, 2021 688.27%
Jun 30, 2021 822.31%
Mar 31, 2021 102.16%
Dec 31, 2020 176.64%
Sep 30, 2020 52.05%
Jun 30, 2020 -8.09%
Mar 31, 2020 -368.88%
Dec 31, 2019 -306.35%
Sep 30, 2019 -308.73%
Jun 30, 2019 -325.95%
Mar 31, 2019 -315.81%
Dec 31, 2018 -314.82%
Sep 30, 2018 -412.89%